For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Attruby represents a true change. These innovative therapies preserve the https://attr-cm248764.mdkblog.com/48297407/major-attr-cm-advance-tafamidis-and-attruby-offer-hope